Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Chubb
Baxter
McKinsey
Teva
Deloitte
Julphar
Express Scripts

Generated: October 20, 2018

DrugPatentWatch Database Preview

Heyl Chemisch Company Profile

« Back to Dashboard

What is the competitive landscape for HEYL CHEMISCH, and what generic and branded alternatives to HEYL CHEMISCH drugs are available?

HEYL CHEMISCH has one approved drug.



Summary for Heyl Chemisch
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Heyl Chemisch

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heyl Chemisch RADIOGARDASE (PRUSSIAN BLUE) ferric hexacyanoferrate(ii) CAPSULE;ORAL 021626-001 Oct 2, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Johnson and Johnson
Federal Trade Commission
Moodys
Harvard Business School
US Department of Justice
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.